select trial semaglutide cardiovascular outcomes non-diabetic 2023 and in Obesity without Diabetes: The GLP-1 medications are rewriting the

Ozempic helps with diabetes and weight loss, but its not without risks

When they do trigger symptoms, they can include steady, severe upper abdominal pain, pain between your shoulder blades or in your right shoulder, nausea, vomiting, fever, chills, or jaundice (yellow skin or eyes)

Settlements and Litigation Strategy: While defending its product, Novo Nordisk has also engaged in strategic settlements in some cases to mitigate legal risks and public relations fallout

Decreased appetite and fatigue

The Novo Nordisk savings programs, patient assistance programs, and pharmacy discount cards like GoodRx and SingleCare can help reduce costs significantly

After 68 weeks, 16% reduction in body weight was noted in those who had received the drug, versus 5.7% in the placebo cohort